🔗 Share this article

An underground economy for unlicensed slimming medications is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.

Experimental Treatment Gaining Traction Via Social Media

Retatrutide, which is still in research studies, is being promoted by online personalities for its alleged fat-burning effects. Followers are encouraged to message these accounts directly for source information, while also receiving discount codes.

Active Commerce on Messaging Platforms

Separately, a robust trade exists on messaging services, where groups with thousands of participants share “before and after” photos, injection guides and assertions of rapid UK delivery. Vendors promote the substance there before redirecting buyers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an investigational injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Early trials indicate it could help individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Professionals Express Concerns

However, doctors and chemists have cautions that the sale of what remains an unlicensed drug in the UK is a cause for concern and could lead to individuals injecting products of unknown origin.

Some professionals said the popularity for the experimental drug could be connected to the increasing cost of approved weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the British medical regulations.

Several content creators try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to penalties, legal action or imprisonment.

Platform Reaction and Content Elimination

Based on the social media company, the service has taken down problematic content and banned associated hashtags and query recommendations. The company said it was dedicated to keeping the service safe and investing in enhancing compliance measures.

Digital Trading Operations

Investigations also found groups with up to nine thousand members marketing the experimental drug using Telegram's built-in search feature, which functions like a online catalog. Entering “retatrutide” immediately brings up channels with numerous of members, filled with images of weight loss, positive testimonials and detailed guides for mixing or administering at home.

After minutes of entering one community, a seller shared contact information, where the majority of transactions take place. The seller provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about weight, medical conditions or previous experience.

Product Details and Costs

Inside these communities, messages display black plastic packages with postal service labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with sterile water, or pre-filled pens usually sold at 160 pounds for 20 milligrams. When questioned how long a pen should last, vendors give contradictory answers varying between a several days to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for the messaging service stated it actively monitored harmful material on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are administering materials they cannot confirm. Although the science behind this drug is valid, these online versions may not contain what they advertise,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the surge in interest to recent price rises for approved slimming medications such as Mounjaro. “With prices increasing, individuals are using online platforms. But counterfeit injections are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she explained.

Her team has previously encountered patients injured by self-injection from unverified sources. “We recognize the frustration, but buying from messaging apps or communication platforms is taking chances with your well-being,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A representative from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a Lilly investigational product not yet approved … may subject users to possibly significant health risks”.